EMA Market Approval Rate for Small Biotechs Skyrocketed Last Year
The success rate for small biotechs applying for regulatory approval from the EMA has risen…
July 14, 2021 - 3 minutes
Orchard Therapeutics
The 21 European Biotech Companies To Watch in 2021
As we enter 2021, the biotech industry is already bustling with activity. Here’s a list…
January 11, 2021 - 11 minutes
4BIO Capital Raises €45M Fund to Invest in Advanced Therapies
The London-based life sciences investor 4BIO Capital has raised €45M in the first close of…
September 9, 2019 - 3 minutes
Orchard’s Gene Therapy Improves Children’s Motor Ability
Orchard Therapeutics' gene therapy for metachromatic leukodystrophy (MLD) resulted in motor ability improvements more than…
September 5, 2019 - 3 minutes
Why Making the Jump from Pharma to Biotech Can be a Life Changing Experience
In less than two years, Orchard Therapeutics has changed from a small, relatively unknown UK…
August 7, 2019 - 13 minutes
Orchard’s Gene Therapy Shows Potential in Treating Patients with Beta Thalassemia
Patients with the life-threatening blood disorder beta-thalassemia required fewer blood transfusions after receiving a gene…
April 30, 2019 - 3 minutes
Gene Therapy Exceeds Expectations in Treating Children’s Neurological Disease
A gene therapy developed by the UK company Orchard Therapeutics has greatly improved the motor…
March 28, 2019 - 3 minutes
Orchard Achieves Good Survival with Cell Therapy for Rare Immune Deficiency
All 20 patients with a rare immunodeficiency disease survived for at least two years after…
February 25, 2019 - 2 minutes
Orchard’s Gene Therapy for Rare Immune Disease Works for Over a Year
A single dose of a gene therapy developed by Orchard Therapeutics can restore immune function…
December 7, 2018 - 3 minutes
Gene Therapy Company’s IPO Shoots it to Billion-Euro Biotech List
Orchard Therapeutics, a British company developing gene therapy for rare genetic diseases, has launched its…
November 1, 2018 - 2 minutes
Orchard Therapeutics Raises €132M to Develop Gene Therapies
Orchard Therapeutics raised $150M (€132M) in Series C financing to bring its gene therapies from…
August 13, 2018 - 2 minutes
FDA Backs Gene Therapy for Fatal Neurodegenerative Childhood Disease
Orchard Therapeutics has received a fourth Rare Pediatric Disease Designation from the FDA for its…
May 3, 2018 - 1 minute
